BDBM292093 4-[4-(4-aminopiperidin-1-yl)-1-(2- methylindazol-5-yl)-6-oxopyrimidin-2-yl]- 2-fluorobenzonitrile::US10100046, Example 31::US9902719, Example 31

SMILES Cn1cc2cc(ccc2n1)-n1c(nc(cc1=O)N1CCC(N)CC1)-c1ccc(C#N)c(F)c1

InChI Key InChIKey=PDSZKPHSJJBAKV-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 292093   

TargetLysine-specific histone demethylase 1A(Human)
Celgene Quanticel Research

US Patent
LigandPNGBDBM292093(US10100046, Example 31 | 4-[4-(4-aminopiperidin-1-...)
Affinity DataIC50: 100nMAssay Description:The enzymatic assay of LSD1 activity is based on Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) detection. The inhibitory properties ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/21/2020
Entry Details
US Patent

TargetLysine-specific histone demethylase 1A(Human)
Celgene Quanticel Research

US Patent
LigandPNGBDBM292093(US10100046, Example 31 | 4-[4-(4-aminopiperidin-1-...)
Affinity DataIC50: 100nMT: 2°CAssay Description:This assay determines the ability of a test compound to inhibit LSD1 demethylase activity. E. coli expressed full-length human LSD1 (Accession number...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2019
Entry Details
US Patent